Posted inBlockchain Innovations
Antimicrobial Resistance: A Growing Economic and Investment Risk in the Biotech and Pharma Sectors
With over 35,000 annual deaths in Europe linked to drug-resistant infections, antimicrobial resistance (AMR) is emerging as a systemic threat to public health and economic stability. This article analyzes its macroeconomic impact, pharmaceutical R&D challenges, and investment implications for biotech and healthcare portfolios.
